VEGF111: new insights in tissue invasion

被引:7
作者
Danastas, Kevin [1 ]
Combes, Valery [2 ]
Lindsay, Laura A. [1 ]
Grau, Georges E. R. [2 ]
Thompson, Michael B. [3 ]
Murphy, Christopher R. [1 ]
机构
[1] Univ Sydney, Sch Med Sci, Bosch Inst, Discipline Anat & Histol, Sydney, NSW 2006, Australia
[2] Univ Sydney, Discipline Pathol, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia
[3] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia
来源
FRONTIERS IN PHYSIOLOGY | 2015年 / 6卷
基金
澳大利亚研究理事会;
关键词
vascular endothelial growth factor; angiogenesis; cancer; metastasis; tumorigenesis; placentation; ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; FACTOR VEGF; TYROSINE KINASE; CELLS SECRETE; ANGIOGENESIS; METASTASIS; CANCER; RECEPTOR; BINDING;
D O I
10.3389/fphys.2015.00002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Vascular endothelial growth factor is a secreted glycoprotein that acts on endothelial cells to induce developmental and physiological angiogenesis. It has also been implicated in angiogenesis occurring in several pathologies, most notably, cancer. Alternative splicing of VEGF mRNA transcripts results in several isoforms with distinct properties depending on their exon composition. Recently, a new isoform has been identified, VEGF(111) with a unique exon composition responsible for its high angiogenic potential. In humans, the only known inducer of VEGF(111) is DNA damage but its natural presence in the uterus of the viviparous lizard, Saiphos equalis, suggests other mechanisms of regulation. Most interestingly, the possible relationship between the evolution of viviparity and the associated increased risk in developing cancer may be important in understanding the mechanisms underlying tumor development.
引用
收藏
页数:5
相关论文
共 43 条
[1]   A ROLE FOR SUNLIGHT IN SKIN-CANCER - UV-INDUCED P53 MUTATIONS IN SQUAMOUS-CELL CARCINOMA [J].
BRASH, DE ;
RUDOLPH, JA ;
SIMON, JA ;
LIN, A ;
MCKENNA, GJ ;
BADEN, HP ;
HALPERIN, AJ ;
PONTEN, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) :10124-10128
[2]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[3]  
D'Souza Alaric W., 2014, Evolution Medicine and Public Health, P136, DOI 10.1093/emph/eou022
[4]   New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation [J].
Delcombel, Romain ;
Janssen, Lauriane ;
Vassy, Roger ;
Gammons, Melissa ;
Haddad, Oualid ;
Richard, Benjamin ;
Letourneur, Didier ;
Bates, David ;
Hendricks, Celine ;
Waltenberger, Johannes ;
Starzec, Anna ;
Sounni, Nor Eddine ;
Noel, Agnes ;
Deroanne, Christophe ;
Lambert, Charles ;
Colige, Alain .
ANGIOGENESIS, 2013, 16 (02) :353-371
[5]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[6]   Vascular endothelial growth factor: Basic science and clinical progress [J].
Ferrara, N .
ENDOCRINE REVIEWS, 2004, 25 (04) :581-611
[7]   PITUITARY FOLLICULAR CELLS SECRETE A NOVEL HEPARIN-BINDING GROWTH-FACTOR SPECIFIC FOR VASCULAR ENDOTHELIAL-CELLS [J].
FERRARA, N ;
HENZEL, WJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :851-858
[8]   TUMOR DORMANCY IN-VIVO BY PREVENTION OF NEOVASCULARIZATION [J].
GIMBRONE, MA ;
COTRAN, RS ;
FOLKMAN, J ;
LEAPMAN, SB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 136 (02) :261-&
[9]   No cancer in cancers: Evolutionary trade-off between successful viviparity and tumor escape from the adaptive immune system [J].
Hayakawa, S .
MEDICAL HYPOTHESES, 2006, 66 (05) :888-897
[10]   THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY - IDENTIFICATION OF A 4TH MOLECULAR-SPECIES AND CHARACTERIZATION OF ALTERNATIVE SPLICING OF RNA [J].
HOUCK, KA ;
FERRARA, N ;
WINER, J ;
CACHIANES, G ;
LI, B ;
LEUNG, DW .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (12) :1806-1814